WSAAI 2020 58th Annual Scientific Session
This year's meeting will cover novel diagnostics and therapeutics involved in severe asthma, the prevention of food allergies as well as cutting edge treatments for food allergies, address the skin as the largest immune organ and discuss other immunodeficiency and hypersensitivity disease.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 22 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by medical education grants from CSL Behring, DBV Technologies, Grifols, GlaxoSmithKline, Optinose, Kaleo, Shire, Sanofi
Allergists and Allied Healthcare Providers
Upon completion of this activity, participants should be able to:
- Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
- Learn how gastroenterologists approach patients with mast cell disorders
- Recognize the current and potential roles of biologics to treat chronic rhinosinusitis
- Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD
- Recognize the benefit or working with gastroenterologists in co-managing inflammatory conditions like eosinophilic esophagitis (EoE)
- Discover novel triggers for hypersensitivity skin diseases such as contact dermatitis
- Recognize how allergists can actively treat food allergies
- 22.00 AMA PRA Category 1 Credit™
- 22.00 Attendance